Characterization of the human endogenous retrovirus K Gag protein: identification of protease cleavage sites by Kraus, Benjamin et al.
RESEARCH Open Access
Characterization of the human endogenous
retrovirus K Gag protein: identification of
protease cleavage sites
Benjamin Kraus, Klaus Boller, Andreas Reuter and Barbara S Schnierle
*
Abstract
Background: Viral genomes of the human endogenous retrovirus K (HERV-K) family are integrated into the human
chromosome and are transmitted vertically as Mendelian genes. Although viral particles are released by some
transformed cells, they have never been shown to be infectious. In general, gammaretroviruses are produced as
immature viral particles by accumulation of the Gag polyproteins at the plasma membrane, which subsequently
bud from the cell surface. After release from the cell, Gag is further processed by proteolytic cleavage by the viral
protease (PR), which results in morphologically mature particles with condensed cores. The HERV-K Gag polyprotein
processing and function has not yet been precisely determined.
Results: We generated a recombinant poxvirus, encoding the human endogenous retrovirus K consensus gag-pro-
pol genes (MVA-HERV-Kcon) and obtained high levels of HERV-K Gag expression. The resulting retroviral particle
assembled at the plasma membrane, as is typical for gammaretroviruses; and immature as well as mature
retrovirus-like particles (VLPs) were observed around the infected cells. VLPs were purified, concentrated and
separated by two-dimensional gel electrophoresis. The HERV-K Gag fragments were identified by mass
spectroscopy and N-terminal sequencing which revealed that HERV-K Gag is processed into MA, a short spacer
peptide, p15, CA and NC.
Conclusion: The cleavage sites of HERV-K Gag were mapped and found to be highly conserved among HERV-K
genomes. The consensus HERV-K gag gene used in this study is known to support viral, infectivity [1], and thus the
cleavage sites that were mapped in this study for all the Gag components are relevant for HERV-K infectivity.
Background
Human endogenous retroviruses (HERVs) are relics of
evolutionary ancient viral infection events which
involved insertion into the germ line and are now trans-
mitted vertically. These retroviral genomes are chromo-
somally integrated in all nucleated cells of an individual
and their sequences, including solitary LTRs, comprise
about 8% of the human genome. HERVs are classified
by the single letter amino acid code for the tRNA speci-
fic to the primer-binding site (PBS) used to initiate
reverse transcription. At present, 11 distantly related
HERV groups with a tRNA lysine (K) PBS exist
(reviewed in [2]). One of these, the HERV-K/HML-2
(hom) group is the only known endogenous retrovirus
group encoding all structural and enzymatic proteins
(proteins encoding the viral core [Gag], UTPase/pro-
tease [PR], polymerase [Pol], RNaseH, integrase [Int]),
and envelope [Env]) and the accessory protein Rec with
functional similarity to the HIV Rev protein [3]. In gen-
eral, HERV-K gene expression is repressed in somatic
cells; however, reactivation of HERV-K proviruses cod-
ing for all viral proteins has been described for human
t e r a t o c a r c i n o m a s[ 4 ] ,a sw e l la sf o rm e l a n o m a s[ 5 ] ,a n d
ovarian cancer [6], [7]. Although full-length genomic
mRNA and viral particles are detectable, HERV-K has
never been shown to be infectious and the viral genome
is only known to be transmitted via the germ line. How-
ever, the HERV-K family may have replicated less than
1 million years ago and a consensus HERV-K sequence
has been constructed that likely resembles the progeni-
tor of HERV-K that entered the human genome within * Correspondence: schba@pei.de
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generated from this consensus HERV-K provirus
sequence [1], [8]. This raises concerns that recombina-
tion between different HERV-K genomes might be able
to form infectious viral genomes able to reinfect human
cells, especially germ cells.
Retroviral Gag polyproteins play a central role in viral
particle formation and are responsible for particle
assembly, release and infectivity. Gag itself is sufficient
for the formation of virus-like particles (VLPs). It is first
synthesized as a polyprotein and is further processed in
viral particles by the viral protease (PR) to produce the
major structural proteins MA (matrix), CA (capsid) and
NC (nucleocapsid). This genetic organization as a poly-
protein precursor that is subsequently cleaved exploits
the protein-protein interactions needed for virion
assembly to ensure the incorporation of the enzymes
needed for replication, maturation and infection. Muta-
tion of the retroviral PR prevents cleavage but does not
prevent assembly of Gag at the plasma membrane and
virus release; however, the resulting particles remain
immature, with a changed morphology that never shows
collapsed cores, and are not infectious.
Cell associated HERV-K particles budding from
human teratocarcinoma cell lines have been shown to
exist exclusively as morphologically immature particles
[9]. However, a functional protease has been detected
[10]. This raises the possibility that a defect in cleavage
is caused by mutated cleavage sites. Therefore, we have
characterized here the HERV-K Gag protein processing
based on the consensus HERV-K genome sequence [1].
Results
HERV-K Gag processing is mediated by the viral protease
Processing of retroviral Gag polyproteins in immature
viral particles is mediated by the viral protease (PR) and
induces a reorganization of the internal virion structure,
termed maturation, which becomes morphologically visi-
ble as collapse of the viral core. Mutation or deletion of
PR prevents cleavage but does not prevent assembly,
resulting in immature particles. A functional protease
has been described for HERV-K [10]. To analyze a
potential defect in Gag cleavage and to obtain high
amounts of HERV-K particles, HERV-K Gag expression
with the help of the modified vaccinia virus Ankara
(MVA) was employed. The consensus HERV-K Gag-PR-
Pol gene [1] was cloned into the MVA expression vector
pIII-mH5 [11] generating the plasmid pIII-HERV-Kcon,
where expression is controlled by a strong early/late
promoter. In addition, we constructed a protease-defi-
cient variant of that construct, named pIII-HERV-Kcon-
pro
-. The transfer plasmids pIII-HERV-Kcon and pIII-
HERV-Kconpro
- were transfected into HEK 293T cells,
and these were infected with MVA to induce transient
expression of the HERV-K gag/pol genes controlled by
the vaccinia virus specific promoter. Subsequent Wes-
tern blot analysis of cell lysates (lys) and concentrated
supernatants (sup) revealed that HERV-K Gag/Pol was
expressed after MVA infection (Figure 1A, lanes 2, 3, 5
and 6) and particles could be pelleted by ultracentrifuga-
tion from supernatants of these cells (lanes 3 and 6).
Particles derived from pIII-HERV-Kcon contained mainly
processed Gag, since the Gag precursor could only be
detected in cell lysates and not in the supernatants
(Figure 1A, lanes 2 and 3). However, only the Gag pre-
cursor could be detected in cell lysates and viral parti-
cles from pIII-HERV-Kconpro
--transfected cells (Figure
1A, lanes 5 and 6). Consequently, processing of HERV-
K Gag was dependent on the presence of the functional
retroviral protease and MVA infection was not responsi-
ble for cleavage products.
HERV-K particles are released from cells infected with
recombinant HERV-K Gag/Pol-expressing MVA
After showing the value of this expression system for
HERV-K Gag processing analysis, we generated a
recombinant MVA stably expressing the HERV-K gag/
pol gene (MVA-HERV-Kcon). The recombinant virus
was constructed as described previously, using K1L
selection [11]. Quality control by PCR and Western blot
analysis confirmed the proper expression of HERV-K
Gag/Pol in cells infected with MVA-HERV-Kcon (Figure
1B, lanes 4 and 5). To further demonstrate that MVA
does not alter the cleavage pattern of Gag, we addition-
ally analyzed cell lysates and concentrated viral particles
from HEK 293T cells transfected with the HERV-K
Gag-PR-Pol expression plasmid which expresses HERV-
K Gag/Pol driven by a CMV promoter 48 hrs after
transfection [1]. Fragments, representing Gag and capsid
or partial cleavage products thereof had the same size
independently if HERV-K Gag/pol was expressed in the
presence or absence of MVA (Figure 1B, lanes 3 and 5).
This is further evidence that processing of HERV-K Gag
mediated by the retroviral protease. In addition, MVA-
driven protein expression is more efficient than plas-
mid-based expression, since only one-third of the MVA-
infected cell material was loaded in Figure 1B and the
infected cells were already harvested 24 hrs after
infection.
To determine if virus-like particles are formed by
MVA-HERV-Kcon-infected cells, NIH3T3 cells were
infected at an MOI of 5 and the cells were fixed 24 h
after infection and analyzed by electron microscopy.
Retroviral particles were detected budding at the cell
surface (Figure 2A) and Figure 2B shows free immature
retroviral particles. Figure 2C shows the presence of
incoming poxviral particles as typically seen after MVA
infection, as well as mature retroviral particles with
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MVA-HERV-Kcon-infected cells could be used to gener-
ate large amounts of HERV-K virus-like particles.
Separation of processed Gag fragments isolated from
VLPs and N-terminal sequence determination
The HERV-K Gag protein has a functional organization
typical for retroviruses. In silico predictions imply an N-
terminal matrix protein (MA) with an N-terminally
myristoylated head, which usually directs Gag to cell
membranes. At the C-terminus are two Zink-finger
motifs, suggesting the location of the nucleocapsid (NC)
protein. The NC binds RNA and enables the packaging
of the viral genome. The central region of the HERV-K
Gag has homology to retroviral capsid (CA) proteins.
CA usually homo-oligomerizes and determines the par-
ticle morphology. Retroviruses also have other proteins
which are generally designated by their molecular
weight, such as p12 of murine leukemia virus; however,
their function is still unknown [12]. Cleavage of in vitro-
translated HERV-K Gag by its purified protease
expressed in E. coli has been shown before [13], but the
exact boundaries and the precise size of processed
HERV-K Gag proteins were unknown.
To study HERV-K Gag processing, HEK 293T cells
were infected at an MOI of 5 for 24 h with MVA-
Figure 2 Morphology of VLPs released from MVA-HERV-Kcon
infected cells. (A) Virus assembly takes place at the cell membrane
as is typically seen for C-type viruses. (B) Free immature particles
and (C) mature particles with condensed cores could also be
observed. Note the MVA particle (arrow) in the HERV-K-producing
cell. Bar in (C) represents 200 nm.
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Figure 1 HERV-K Gag polyprotein cleavage requires a functional retroviral protease. Western blot analysis of HERV-K Gag, expressed by
transient vaccinia virus-driven expression. HERV-K Gag was detected with the HERV-K CA-specific monoclonal antibody mix HERMA [9] and an
HRP-coupled anti-mouse antibody followed by ECL detection (Amersham, Freiburg). A: Lys: cell lysates; sup: concentrated cell culture
supernatants. Lanes 1-3: HERV-K Gag expression with a functional protease; Lanes 4-6: HERV-K Gag expression without protease; +: plasmid
transfection with additional MVA infection. Positions of the Gag polyprotein and CA are indicated. B: Lys: cell lysates; sup: concentrated cell
culture supernatants. Lane 1: lysate of untreated 293T cells; lanes 2-3: plasmid driven HERV-K Gag expression, samples prepared 48 hrs after
transfection; Lanes 4-5: MVA-HERV-Kcon driven HERV-K Gag expression, samples prepared 24 hrs after infection. The loading volume was one-third
of the volume used in lanes 1, 2 and 3.
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concentrated by ultracentrifugation through a sucrose
cushion. To analyze the Gag cleavage products in VLPs,
two-dimensional (2-D) electrophoresis was employed.
The concentrated virus-like particles were first subjected
to isoelectric focusing, followed by SDS-PAGE as the
second dimension (Figure 3). The gel was stained with
C o o m a s s i ed y ea n ds i n g l ep r o t e i n sw e r ec u to u ta n d
analyzed by mass spectrometry (MS). With the excep-
tion of one spot (Figure 3A, indicated by a black circle),
all spots analyzed corresponded to HERV-K sequences.
As a control, the same procedure was performed with
wt MVA-infected cells and, as expected, no proteins
were detected in the 2-D analysis (data not shown).
Figure 3B summarizes the results, and color coding indi-
cates the regions in HERV-K Gag corresponding to pep-
tide sequences obtained by MS of 2-D separated
proteins. Table 1 gives a summary of the peptide frag-
ments obtained by MS analysis. The mass spectrometry
did not allow for the identification of the exact cleavage
site boundaries. Therefore, we once more purified
HERV-K particles from MVA-HERV-Kcon-infected HEK
293T cells and separated the proteins by 2-D electro-
phoresis and blotted them onto a PVDF membrane.
Ponceau S-stained protein spots were cut out and N-
terminal sequencing was performed. Table 2 gives a
summary of the identified cleavage sites. The isoelectric
point (pI) and the molecular weight (MW) were calcu-
lated for the protein fragments and correlated with the
2-D analysis (Figure 3A). Consequently, we propose a
cleavage pattern of HERV-K as indicated in Figure 3B,
with the following fragments:
- An apparently myristoylated MA of 15.2 kDa, which
does not match the calculated pI of 9.1 but is rather
pH3 pH10 A p p
148 kDa
98
64
50
36
16 16
Z Fi myristylation
Capsid Matrix P15 NC
ZnͲFinger
(CYNCGQIGHLKKNC) (CPRCKKGKHWASQC) B
HERVͲKGag
Sp1
Figure 3 Mapping of HERV-K Gag protease cleavage sites. (A) VLPs from MVA-HERV-Kcon-infected cells were pelleted by ultracentrifugation
and separated by 2-D gel electrophoresis. The gel was stained with Coomassie and the indicated spots were analyzed by mass spectrometry
and N-terminal sequencing. (B) Graphic scheme of HERV-K Gag, the experimentally determined processing products and in silico predictions.
Colors indicate the analyzed spots isolated by 2-D gel electrophoresis.
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phosphorylation.
- A short peptide SP1-HK.
- The p15, with a pI of 8.1 and MW of 15.1 kDa.
- The slightly over-presented, uncleaved product of
SP1-HK and p15 with a pI of 5.9 and MW of 16.5 run-
ning in the middle of the 2-D gel (Figure 3A).
-C A ,w i t hap Io f6 . 3a n dM W2 7 . 5k D a .T h ei d e n t i -
fied N-terminal cleavage site for CA matches the aro-
matic amino acid/proline sequence at the scissile bond
consistently found at the N-terminus of CA proteins of
retroviruses.
- NC, with a pI of 9.6 and a MW of 14.6 kDa.
The p15 and the SP1-HK/p15 proteins display two
spots in the 2-D analysis. This might result from protein
phosphorylation, which changes the pI and can also
affect protein mobility in SDS-PAGE analysis. In addi-
tion, we detected multiple spots of lower abundance for
CA in the 2-D analysis, which might result from post-
translational modification, such as phosphorylation [14].
Discussion
The human genome encodes a large number of endogen-
ous retroviral sequences, which encompass about 8% of
the total genome. Human endogenous retroviruses
(HERV) are transmitted vertically and are considered to
be non-replicating, since almost all HERV genomes have
inactivating mutations. Only HERV-K has retained its
capability to form viral particles, but there are no signs of
infectivity. Little is known about the biological function
of HERV-K expression, which has been detected in some
tumor entities, such as human teratocarcinomas [4], and
the basic virology has still not been investigated properly.
In order to elucidate the hypothetical defect in Gag pro-
cessing and–as a consequence–in virus infectivity, we
mapped the previously unknown proteolytic cleavage
sites of the HERV-K Gag polyprotein.
HERV-K virus-like particles based on the HERV-K con-
sensus sequence were produced with the help of a recom-
binant poxvirus expressing the HERV-K Gag, the protease
(PR) and the polymerase (Pol), and harvested from super-
natants of the infected cells. The production of retrovirus-
like particles by vaccinia virus (VACV) expression of the
gag/pol genes is well established and has been described
previously, for example for HIV-1 [15], and transduction-
competent retroviral vectors have also been produced
[16]. Moreover, VACV-produced HIV-1 particles have
been used to test early HIV protease inhibitors and it
could be shown that HIV-1-like particles released from
inhibitor-treated cells contain e da l m o s te x c l u s i v e l yt h e
Gag precursor but no cleaved Gag products [17]. We used
the highly attenuated MVA instead of replication-compe-
tent VACV which increased the safety of our work and
provided proof of concept that MVA is also suitable for
producing VLPs for biochemical analysis.
HERV-K particles were released from MVA-HERV-
Kcon-infected cells, showing a typical gammaretrovirus
morphology with assembly of the virus core at the cyto-
plasma membrane and extracellular particles of imma-
ture and mature morphology, with a condensed, acentric
core (Figure 2C), similar to HERV-K113 particles pro-
duced by recombinant baculovirus expression [18] or
HTDV/HERV-K expressed by teratocarcinoma cell lines
[19]. HERV-K Gag proteolytic cleavage was dependent
on the presence of its functional protease and potential
poxvirus-encoded proteases could not cleave Gag in the
absence of the viral protease (Figure 1).
In silico prediction of retroviral protease cleavage sites
is not possible, because there is no clear consensus
Table 1 Summary of the peptide fragments obtained by MS analysis
Gag
domains
Peptides found by MS analysis
(AA position)
Matrix 31STKNLIKLFQIIEQFCPWFPEQGTLDLK58
74GNIIPLTVWNDWAIIKAALEPFQTEEDSVSVSDAPGSCIIDCNENTR120
P15 171VGPSESKPRGTSPLPAGQVPVTLQPQK197
241APYPQPPTR249
260QGSELHEIIDK270
Capsid 324QYGPNSPYMRTLLDSIAHGHRLIPYDWEILAKSSLSPSQFLQFKTWWIDGVQEQVR379
383AANPPVNIDADQLLGIGQNWSTISQQALMQNEAIEQVR420
430IQDPGSTCPSFNTVRQGSKEPYPDFVAR457
499VPAGSDVISEYVK511
NC 565QNITIQATTTGREPPDLCPR 584
602NGQPLSGNEQR 612
The amino acid position within the Gag protein and an allocation to the Gag subfragments are indicated.
Table 2 Summary of the sequences obtained from N-
terminal sequencing of HERV-K Gag cleavage products.
Gag domains Protease cleavage sites
(AA position)
Gag domains
Matrix LHCEY134 135VAEPV SP1-HK
SP1-HK TQNVD148 149YNQLQ P15
P15 EAWQF282 283PVTLE Capsid
Capsid QAITG532 533VVLGG Nucleocapsid
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conformation to fit into the active site to be hydrolyzed
[20]. Therefore, we identified the cleavage sites by a
combination of 2-D electrophoresis, mass spectrometry
and N-terminal sequencing, and could draw a map of
Gag as illustrated in Figure 3B. The N-terminal cleavage
site for HERV-K CA matched the sequence consistently
found at the N-terminus of all retroviral CA proteins.
The other cleavage sites correspond well to the simpli-
fied version of a cleavage site as an amino acid stretch
that is hydrophobic and both accessible and flexible, i.e.
apparently the space between separately folded domains
of Gag. HERV-K Gag is processed into MA, a short
spacer peptide, p15, CA and NC. This structure is simi-
lar to mouse mammary tumor virus (MMTV). Interest-
ingly, MMTV is morphologically a B-type virus where
core assembly takes place inside the cytoplasma and
only the preformed core migrates to the cell membrane.
In addition, we found late (L)-domain motifs in the p15
protein of HERV-K, similar to Rous sarcoma virus, mur-
ine leukemia virus, and Mason-Pfizer monkey virus
(MPMV), in which the L-domains also reside between
MA and CA. In contrast, the late domains of HIV are
located in the C-terminal p6 protein of Gag. L-domains
are needed for efficient pinching off of the budding viral
particles and different retroviruses utilize different viral
proteins to accomplish late budding function [21].
Conclusion
The retroviral Gag protein is of high importance for ret-
roviruses: it mediates the intracellular transport to the
cell membrane, directs assembly of virus particles, and
facilitates the budding of the viral particles. Blast align-
ment of all HERV-K Gag sequences showed that the clea-
vage sites identified here are highly conserved, and we
could not detect a sequence change in the cleavage sites
of any of the genomes available in the databases. This
suggests that cleavable Gag proteins could be expressed
by all HERV-K genomes and that the defect in replication
must reside at a different step in the viral life cycle. On
the other hand, this also suggests that recombination
between HERV-K genomes or other retroviruses like
HIV or XMRV [22] might give rise to novel infectious
viral genomes able to reinfect human cells.
Note added in proof:
The same cleavage sites were obtained from Norbert
Bannert’s group (Robert Koch Institute, Berlin) using a
different technical approach (George et al., manuscript
in preparation).
Methods
Cell culture
HEK 293T, BHK21, RK-13 and NIH3T3 cells were cul-
tured in complete Dulbecco’s modified Eagle’sm e d i u m
(DMEM) containing 10% fetal bovine serum, penicillin
(50 U/ml), streptomycin (50 μg/ml), and L-glutamine (2
mM), and propagated by standard techniques. Transient
MVA expressions were performed by transfection of the
transfer plasmid and subsequent MVA infection at an
MOI of 5. Transfections were performed with Fugene™
(Roche/Mannheim) in 6-well or 10 cm plates according
to the manufacturer’s instructions. At 24 h post trans-
fection, cells were lysed for SDS-PAGE separation [23],
fixed for EM or supernatants were collected for VLP
purification. For collection of HERV-Kcon VLPs, HEK
293T cells were infected with MVA-HERV-Kcon at an
MOI of 5 for 24 h under serum-free conditions before
supernatants were harvested.
Virus and plasmid construction
The consensus HERV-K gag/pol gene HERV-Gag-PR-Pol
[1] was kindly provided by Paul Bieniasz. Sequences were
excised by Not1 digestion, treated with T4-DNA polymer-
ase to generate blunt ends, and cloned into the blunted
BamH1 site of MVA expression plasmid pIII-pmH5 to
generate the MVA vector plasmids pIII-HERV-Kcon.T h e
protease-deficient clone pIII-HERV-Kconpro
- was gener-
ated via the following cloning steps: HERV-Kcon sequences
were excised from pCRVI/Gag-PR-Pol [1] by Not1 diges-
t i o na n dc l o n e di n t ot h eNot1s i t eo ft h ep C M V - 3F l a g
plasmid (Agilent Technologies, Waldbronn). Subse-
quently, the unique Spe1 site located upstream of HERV-
K PR active center was cut, blunted and religated, resulting
in a frameshift and introducing a stop codon. The HERV-
Kconpro
- sequence was cut out by Not1a n di n t r o d u c e d
into pIII-mH5 as described above to generate the MVA
vector plasmid pIII-HERV-Kconpro
-.
The recombinant virus MVA-HERV-Kcon was gener-
ated in BHK21 cells by transfection with 1 μg of plasmid
DNA, infection at an MOI of 0.05 with MVA-IInew iso-
late, and plaque selection on RK-13 cells [24], [11]. The
recombinant MVA genomes were analyzed by PCR to
verify HERV-K gag/pol gene insertion and genetic stabi-
lity. The production of HERV-K antigens was confirmed
by Western blot analysis of various cell lysates harvested
after infection with the recombinant MVA-HERV-Kcon
(data not shown). Multiple-step growth analysis in
chicken embryo fibroblasts (CEFs) demonstrated that
the replication capacities of MVA-HERV-Kcon were
comparable to non-recombinant MVA (data not shown).
Ultracentrifugation of cell supernatants
HERV-K VLPs were separatedf r o mM V Ab yf i l t r a t i o n
through 0.2 μm filters and concentrated by ultracentri-
fugation of cell supernatants through a 30% sucrose
cushion for 2 h at 4°C and 130,000 × g. The viral pellet
was resuspended in 150 μl rehydration buffer for 2-D
analysis or in 50 μl sample buffer for SDS-PAGE.
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HERV-K VLP-containing pellets obtained by ultracentri-
fugation of MVA-HERV-Kcon-infected HEK 293T cells
were resuspended in 150 μl rehydration buffer (8 M urea;
1% CHAPS; 10 mM DTT; 0.25% ampholyte) and used to
rehydrate a ReadyStrip IPG Strip pH 3-10 (Bio-Rad,
Munich). Samples were isoelectrically focused using a
standardized program (20 min 250 V; 2 h 4000 V; 10000
Vh 4000 V). After isoelectric focusing, strips were equili-
brated for the second dimension in equilibration buffer
(6 M urea; 30% glycerin; 2% SDS; 50 mM Tris pH 8.8)
plus 1% DTT (w/v) for 15 min and in equilibration buffer
plus 20% iodoacetamide (w/v) for further 15 min. Isoelec-
trically focused samples were separated via 15% SDS-
PAGE with standard techniques followed by Western
blot or Coomassie staining for mass spectrometry.
Western blot
W e s t e r nb l o tw a sp e r f o r m e dw i t haB I O - R a ds e m i - d r y
blotter. Proteins separatedb yS D S - P A G Ew e r eb l o t t e d
onto PVDF membranes with 50 mM sodium borate pH
9.0, 20% methanol, and 0.1% SDS at 100 mA per mem-
brane for 75 min. Afterwards, membranes were either: (1)
washed with water and stained with Ponceau S (Sigma
Aldrich, Hamburg), and protein spots were cut out and
washed extensively with water for N-terminal Edman
amino acid sequencing http://proteome-factory.com; or
(2) blocked with Roti-Block™ and proteins were detected
with a-HERV-K capsid monoclonal antibodies [9] and the
ECL detection system (Amersham, Freiburg).
Electron microscopy
Cells were fixed with 2.5% glutaraldehyde in culture
medium for 45 min at room temperature. After washing
in PBS, cells were scraped off the culture disk and gently
m i x e dw i t h2 %w a r ml i q u i da garose. After cooling and
gelling, small agarose blocks containing the cells were
cut. These blocks were post-fixed with 2% osmium tetr-
oxide in PBS and treated with 1% tannic acid to improve
visibility of viral surface proteins [25]. Cells were then
dehydrated in a graded series of ethanol and finally
embedded in epoxy resin (Sigma-Aldrich, Steinheim)
according to standard preparation protocols. Ultrathin
sections were stained with 2% uranylacetate for 15 min
followed by 2% lead citrate for 5 min.
Mass spectrometry
Protein spots of interest were excised from Coomassie-
stained 2-D gels, destained, reduced, alkylated and
digested with trypsin as described elsewhere [26]. As a
modification of this method, peptides were eluted with
25 mM NH4HCO3 in 10% acetonitrile (ACN) and the
digestion was stopped by adding 5% formic acid. The
peptides were separated with a nano-Acquity UPLC
(Waters, Milford, USA) using a 5 μms y m m e t r y1 8 0μm
× 20 mm c18 pre-column and a 1.7 μm BEH130 100
μm × 100 mm c18 separation column at a flow rate of
500 nl applying a gradient of 30 min (3% ACN to 40%
ACN). The UPLC was coupled to a Nano-ESI Synapt
mass spectrometer (Waters) operated in V mode,
acquiring MS
E data and applying standard parameters.
Data analysis was performed with the Protein Lynx Glo-
bal Server Version 2.3 (Waters). Protein hits were
accepted at a false positive rate of less than 4%; peptide
mass accuracy was 5 ppm or better.
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